<code id='914BC13BCE'></code><style id='914BC13BCE'></style>
    • <acronym id='914BC13BCE'></acronym>
      <center id='914BC13BCE'><center id='914BC13BCE'><tfoot id='914BC13BCE'></tfoot></center><abbr id='914BC13BCE'><dir id='914BC13BCE'><tfoot id='914BC13BCE'></tfoot><noframes id='914BC13BCE'>

    • <optgroup id='914BC13BCE'><strike id='914BC13BCE'><sup id='914BC13BCE'></sup></strike><code id='914BC13BCE'></code></optgroup>
        1. <b id='914BC13BCE'><label id='914BC13BCE'><select id='914BC13BCE'><dt id='914BC13BCE'><span id='914BC13BCE'></span></dt></select></label></b><u id='914BC13BCE'></u>
          <i id='914BC13BCE'><strike id='914BC13BCE'><tt id='914BC13BCE'><pre id='914BC13BCE'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:6844
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          With clinical trial data readouts, here's how to spot spin
          With clinical trial data readouts, here's how to spot spin

          AdobeInvestors,analysts,doctors,andevenpatientsfaceanavalancheofnewsfrombiotechcompaniesabouttheirhu

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          CDC director unscathed in first congressional testimony

          CDCDirectorMandyCohenWinMcNamee/GettyImagesWASHINGTON—HouseRepublicanssoughtThursdaytohammertheCente